GlassScriptPhysician profile
Melanie E Griem
NPI 1407801582
$2,611.45
in general payments reported to CMS, 2019-2025
21 companies · $1,162 in 2025
The $1,162 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.56 · 2020: $17.98 · 2021: $17.15 · 2022: $253 · 2023: $502 · 2024: $641 · 2025: $1,162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,204 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,204.34 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $463.78 | 2021-2025 | |
| Genzyme Corporation | $288.56 | 2022-2025 | |
| Janssen Biotech, INC. | $269.79 | 2024-2025 | Tremfya, Simponi Aria, Simponi |
| Ucb, INC. | $245.92 | 2023-2025 | Bimzelx |
| Novartis Pharmaceuticals Corporation | $191.72 | 2023-2025 | |
| Pfizer INC. | $184.95 | 2022-2025 | |
| Lilly USA, LLC | $182.36 | 2023-2025 | Ebglyss, Taltz, Olumiant |
| Arcutis Biotherapeutics, INC. | $139.22 | 2023-2025 | Zoryve |
| Regeneron Healthcare Solutions, INC. | $104.81 | 2022-2025 | Dupixent |
| Galderma Laboratories, L.P. | $91.44 | 2025 | Nemluvio |
| E.R. Squibb & Sons, L.L.C. | $72.11 | 2023-2024 | Sotyktu |
| Epi Health, LLC | $70.43 | 2020-2022 | |
| Sun Pharmaceutical Industries INC. | $62.85 | 2023-2025 | Winlevi |
| Amgen INC. | $44.65 | 2022-2025 | Otezla |
| Dermavant Sciences, INC. | $39.98 | 2023-2024 | Vtama |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $38.06 | 2022-2025 | Anzupgo |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $37.03 | 2024 | Cabtreo, Jublia, Arazlo |
| Organon LLC | $33.63 | 2025 | Vtama |
| Celgene Corporation | $18.56 | 2019 | |
| Biofrontera INC. | $16.48 | 2024 | Xepi, Bf-Rhodoled, Ameluz |
| Journey Medical Corporation | $15.12 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melanie Griem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.